Preventive effects of 5-fluorouridine and uridine on d-galactosamine-induced liver injury.
D000818:Animals; D002466:Cell Nucleolus / Q000648:ultrastructure; D056486:Chemical and Drug Induced Liver Injury / Q000209:etiology / Q000517:prevention & control*; D005260:Female; D005688:Galactosamine / Q000037:antagonists & inhibitors* / Q000378:metabolism; D008099:Liver / Q000187:drug effects; D012313:RNA / Q000096:biosynthesis; D051381:Rats; D014529:Uridine / Q000031:analogs & derivatives* / Q000378:metabolism / Q000494:pharmacology*; D014530:Uridine Diphosphate / Q000378:metabolism; D014532:Uridine Diphosphate Glucose / Q000378:metabolism; D014539:Uridine Diphosphate Sugars / Q000378:metabolism; D014544:Uridine Triphosphate / Q000378:metabolism
D014539:Uridine Diphosphate Sugars; C001943:5-fluorouridine; D014530:Uridine Diphosphate; D012313:RNA; D005688:Galactosamine; D014544:Uridine Triphosphate; D014532:Uridine Diphosphate Glucose; D014529:Uridine